300028794593

The barcode 300028794593 corresponds to the insulin pen device "Humalog Mix75/25" manufactured by Eli Lilly.

The Humalog Mix75/25 is an intermediate-acting insulin analog replacement therapy used to control high blood sugar levels in adults with diabetes. The product contains a combination of 75% insulin lispro and 25% insulin human protamine, designed to provide a gradual increase in insulin activity over 5 hours.

As with any insulin product, there are potential side effects and warnings associated with the Humalog Mix75/25:

1. Common side effects: Injection site reactions (redness, swelling, itching), hypoglycemia (low blood sugar), nausea, vomiting, and allergic reactions.
2. Serious side effects: Anaphylaxis (severe allergic reaction), diabetic ketoacidosis (high blood acidity), lactic acidosis (poisonous buildup in the body), and pancreatitis (inflammation of the pancreas).
3. Contraindications: Patients with a history of hypersensitivity reactions to insulin lispro or human protamine, severe kidney or liver disease, or thyroid cancer.
4. Precautions: Monitor blood glucose levels regularly, especially when starting or changing insulin therapy, and report any signs of hypoglycemia or hyperglycemia (high blood sugar) promptly.

The Humalog Mix75/25 is available in various packaging configurations, including pens with 3 mL and 5.7 mL cartridges, as well as prefilled pens.

Prices for the Humalog Mix75/25 can vary depending on location, pharmacy, and availability:

• A single 3 mL pen: around $120-$180 USD
• A 5.7 mL pen (standard size): approximately $200-$300 USD
• A prefilled pen (e.g., Humalog Mix75/25 KwikPen): around $250-$350 USD

Please note that prices may differ depending on insurance coverage, sales promotions, and regional market conditions.

Health-related disclaimers for consumable products like insulin pens typically state that the product is intended to treat specific medical conditions and should be used under the guidance of a healthcare professional. It also warns users about potential side effects, allergic reactions, and interactions with other medications.

In this case, the Humalog Mix75/25 is designed to be administered via injection under the skin or under the tongue for use in adults with diabetes. As such, there are no additional disclaimers for consumable products specific to insulin pens.